Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five-year experience with non penetrating deep sclerectomy.

M Detry-Morel1, M B Detry

  • 1St. Luc University Hospital, Université Catholique de Louvain, Brussels. detry@ofta.ucl.ac.be

Bulletin De La Societe Belge D'Ophtalmologie
|May 10, 2006
PubMed
Summary

Non-penetrating deep sclerectomy (DS) is safe and effective for open-angle glaucoma. Combining DS with implants or antimetabolites showed varied complication rates but good long-term IOP control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The range of the waveform score of the ocular response analyzer (ora) in healthy subjects.

Bulletin de la Societe belge d'ophtalmologie·2014
Same author

Paper retracted from BSBO 316. "What do we know about trachoma in the economically weakest infantile population of Kara in Togo?".

Bulletin de la Societe belge d'ophtalmologie·2011
Same author

[Is myopia a risk factor for glaucoma?].

Journal francais d'ophtalmologie·2011
Same author

[The six keys of the monitoring of the glaucoma patient].

Bulletin de la Societe belge d'ophtalmologie·2011
Same author

Haab's striae.

Bulletin de la Societe belge d'ophtalmologie·2011
Same author

Ophthalmoscopic presentation of presumed retinal glial cell activation (ARAM) in a glaucoma patient.

Bulletin de la Societe belge d'ophtalmologie·2010

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Management

Background:

  • Open-angle glaucoma requires effective long-term intraocular pressure (IOP) management.
  • Non-penetrating deep sclerectomy (DS) is a surgical option for medically uncontrolled glaucoma.
  • Assessing the impact of surgical adjuvants on DS outcomes is crucial.

Purpose of the Study:

  • To evaluate the long-term safety and effectiveness of non-penetrating deep sclerectomy (DS).
  • To compare postoperative complications and IOP results based on the use of surgical adjuvants (implant devices, antimetabolites, or both).

Main Methods:

  • Retrospective study of 171 eyes with open-angle glaucoma.
  • Procedures followed Kozlov's and Memoud's techniques for DS.
  • Surgical adjuvants included implant devices (SKGEL, T-FUX) and/or antimetabolites (5-FU, mitomycine C).

Related Experiment Videos

Main Results:

  • Mean follow-up of 39.6 months.
  • Complications included hyperfiltration (15.8%), scarring (22.2%), and iris incarceration (5.8%).
  • YAG gonioperforation was required in 63% of cases.

Conclusions:

  • Non-penetrating deep sclerectomy (DS) demonstrates long-term safety and effectiveness in managing open-angle glaucoma.
  • The use of surgical adjuvants influences complication profiles but supports sustained IOP reduction.
  • Further research into optimizing adjuvant use in DS surgery is warranted.